Please use this identifier to cite or link to this item:
Title: Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology Group
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Anemia/chemically induced,Antineoplastic Combined Chemotherapy Protocols/administration & dosage/*adverse,effects,Breast Neoplasms/*drug therapy/pathology,Carboplatin/administration & dosage/adverse effects,Epirubicin/administration & dosage/adverse effects,Female,Hematologic Diseases/*chemically induced,Humans,Middle Aged,Neutropenia/chemically induced,Paclitaxel/administration & dosage/adverse effects,Prognosis,Retrospective Studies,Thrombocytopenia/chemically induced
ISSN: 0250-7005
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Briasoulis-2008-myelotoxicity as a.pdf235.57 kBAdobe PDFView/Open    Request a copy

This item is licensed under a Creative Commons License Creative Commons